Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications

Journal of Pharmaceutical Sciences

Volumn 88, Issue 1, 1999, Pages 79-88

  Kerwin, Bruce A ^a   Akers, Michael J ^b   Apostol, Izydor ^c   Moore Einsel, Camille ^c   Etter, Jeffrey E ^d   Hess, Edward ^c   Lippincott, Julie ^c   Levine, Joseph ^c   Mathews, Antony J ^c   Revilla Sharp, Patricia ^c   Schubert, Ross ^c   Looker, Douglas L ^c  

^a AMGEN INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Baxter Hemoglobin Therapeutics Inc   (United States)

^d RxKinetix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; BETA GLOBIN; DEOXYHEMOGLOBIN; HEMOGLOBIN;

ARTICLE; AUTOOXIDATION; DRUG FORMULATION; DRUG PROTEIN BINDING; OXYGEN AFFINITY; OXYGEN TENSION; PH; PROTEIN MODIFICATION; PROTEIN STABILITY;

EID: 0032957319     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js980221r     Document Type: Article

References (50)

1. Looker, D.; Abbott-Brown, D.; Cozart, P.; Durfee, S.; Hoffman, S.; Mathews, A. J.; Miller-Roehrich, J.; Shoemaker, S.; Trimble, S.; Fermi, G.; Komiyama, N. H.; Nagai, K.; Stetler, G. A human recombinant haemoglobin designed for use as a blood substitute. Nature 1992, 356, 258-260.
2. Brantley, R. E., Jr.; Smerdon, S. J.; Wilkinson, A. J., Singleton, E. W.; Olson, J. S. The mechanism of autoxidation of myoglobin. J. Biol. Chem. 1993, 268, 6995-7010.
3. Misra, H. P.; Fridovich, I. The generation of superoxide radical during the autoxidation of hemoglobin. J. Biol. Chem. 1972, 247, 6960-6962.
4. Wever, R.; Oudega, B.; Van Gelder, B. F. Generation of superoxide radicals during the autoxidation of mammalian oxyhemoglobin. Biochim. Biophys. Acta 1973, 302, 475-478.
5. Hargrove, M. S.; Whitaker, T.; Olson, J. S.; Vali, R. J.; Mathews, A. J. Quaternary structure regulates hemin dissociation from human hemoglobin. J. Biol. Chem. 1997, 272, 17385-17389.
6. Harvey, J. W.; Kaneko, J. J. Oxidation of human and animal haemoglobins with ascorbate, acetylphyenylhydrazine, nitrite and hydrogen peroxide. Br. J. Haem. 1976, 32, 193-203.
7. Sonaye, B.; Naik, A. A.; Yadav, S. D.; Chakrabarti S. Protein cross-linking during oxidative denaturation of methaemoglobin. Ind. J. Med. Res. 1995, 101, 75-80.
8. Thillet, J.; Michelson A. M. Oxidation and cross-linking of human hemoglobins by activated oxygen species. Free Rad. Res. Comms. 1985, 1, 89-100.
9. Steffek, R. P.; Thomas M. J. Hydrogen peroxide modification of human oxyhemoglobin. Free Rad. Res. Comm. 1991, 12-13, 489-497.
10. Rachmilewitz, E. A. Formation of hemichromes from oxidized subunits. Ann. N. Y. Acad. Sci. 1969, 165, 171-184.
11. Rachmilewitz, E. A.; White J. M. Haemichrome formation during in-vitro oxidation of Hb Koln. Nature (New Biol.) 1973, 241, 115-117.
12. Cho, K. C.; Choy, C. L. Thermal stability of hemoglobin and myoglobin effect of spin states. Biochim. Biophys. Acta 1980, 622, 320-330.
13. Muller, R. G.; Schmid, K. Enthalpy of denaturation for human hemoglobin in the oxygenated and deoxygenated state. Therm. Acta 1983, 69, 115-125.
14. Reider, R. F. Hemoglobin stability: Observations on the denaturation of normal and abnormal hemoglobins by oxidant dyes, heat and alkali. J. Clin. Inv. 1970, 49, 2369-2376.
15. Lambeth, D. O.; Palmer G. The kinetics and mechanism of reduction of electron-transfer proteins and other compounds of biological interest by dithionite. J. Biol. Chem. 1973, 248, 6095-6103.
16. Dalziel, K.; O'Brien, J. R. P. Side reactions in the deoxygenation of dilute oxyhaemoglobin solutions by sodium dithionite. Biochem. J. 1957, 67, 119-124.
17. Dixon, H. B. F.; McIntosh R. Reduction of methaemoglobin in haemoglobin samples using gel filtration for continuous removal of reaction products. Nature 1967, 273, 399-400.
18. Handbook of Pharmaceutical Excipients; Wade, A.; Weller P. J., Eds.; The Pharmaceutical Press: London, 1994; pp 451-453.
19. Gibson, Q. H. The reduction of methaemoglobin by ascorbic acid. Biochem. J. 1943, 37, 615-618.
20. Vestling, C. S. The reduction of methemoglobin by ascorbic acid. J. Biol. Chem. 1942, 143, 439-446.
21. Al-Ayash, A. I.; Wilson, M. T. The mechanism of reduction of single-site redox proteins by ascorbic acid.. Biochem. J. 1979, 177, 641-648.
22. Huffman, S. J.; Looker, D. L.; Roehrich, J. M.; Cozart, P. E.; Durfee, S. L.; Tedesco, J. L.; Stetler G. L. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 1990, 8, 8521.
23. Wikowska, H. E.; Bitsch, F.; Shackleton, C. H. Expediting rate variant hemoglobin characterization by combined HPLC/ electrospray mass spectrometry. Hemoglobin 1993, 17, 227-242.
24. Lippincott, J.; Hess, E.; Apostol I. Mapping of recombinant hemoglobin using imobilized trypsin cartridges. Anal. Biochem. 1997, 252, 314-325.
25. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
26. Kerwin, B. A.; Hess, E.; Lippincott, J.; Kaiser, R.; Apostol I. Oxygen and ascorbate mediated modification of a recombinant hemoglobin. In Techniques in Protein Chemistry VIII; Marshak D. R., Ed.; Academic: New York, 1997; pp 399-407.
27. Apostol, I.; Aitken, J.; Levine, J.; Lippinicott, J.; Davidson, J. S.; Abbott-Brown, D. Recombinant protein sequences can trigger methylation of N-terminal amino acids in Escherichia coli. Protein Sci. 1996, 4, 2616-2618.
28. DeVenuto, F. Stability of hemoglobin solution during extended storage. J. Lab. Clin. Med. 1978, 92, 946-952.
29. Kramlova, M.; Pristoupil, T. I.; Ulrych, S.; Hrkal, Z. Stromafree haemoglobin solution for infusion: Changes during storage. Haematologia 1976, 10, 365-371.
30. Keilin, D. The oxidation of haemoglobin to methaemoglobin by oxygen. II. The relation between the rate of oxidation and the partial pressure of oxygen. Proc. R. Soc. London, Ser. B. 1935, 118, 560-577.
31. Stocker, R.; Frei B. Endogenous antioxidant defences in human blood plasma. In: Oxidative Stress, Oxidants and antioxidants; Sies H, Ed.; Academic: New York, 1991; pp 224-225.
32. Levine, J.; Weickert, M.; Pagratis, M.; Etter, J.; Mathews, A.; Fattor, T.; Lippincott, J.; Apostol, I. Identification of a nickel(II) binding site on hemoglobin which confers susceptibility to oxidative deamination and intramolecular cross-linking. J. Biol. Chem. 1998, 273, 13037-13046.
33. Kang, S.-O.; Snapper, H.; Lohman, W. The oxidative degradation of L-ascorbic acid via an a-keto aldehyde. Z. Naturforsch 1982, 37, 1064-1069.
34. Kimoto, E.; Tanaka, H.; Ohmoto, T.; Choami, M. Analysis of the transformation products of dehydro-L-ascorbic acid by ion-pairing high-performance liquid chromatography. Anal. Biochem. 1993, 214, 38-44.
35. Washko, P. W.; Welch, R. W.; Dhariwal, K. R.; Wang, Y.; Levine M. Ascorbic acid and dehyrdoascorbic acid analyses in biological samples. Anal. Biochem. 1992, 204, 1.
36. Kurata, T.; Sakurai Y. Degradation of L-ascorbic acid and mechanism of nonezymic browning reaction. Agr. Biol. Chem. 1967, 31, 177-184.
37. Davies, K. J. A.; Delsignore, M. E.; Lin S. W. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J. Biol. Chem. 1987, 262, 9902-9907.
38. Li, S.; Schoneich, C.; Wilson, G. S.; Borchardt, R. T. Chemical pathways of peptide degradation. V. Ascorbic acid promotes rather than inhibits the oxidation of methionine to methionine sulfoxide in small model peptides. Pharm. Res. 1993, 10, 1572-1579.
39. Braun, K. P.; Pavlovich, J. G.; Jones, D. R.; Peterson C. M. Stable acetaldehyde adducts: structural characterization of acetaldehyde adducts of human hemoglobin N-terminal β-globin chain peptides. Alcohol Clin. Ex.p Res. 1997, 21, 40-43.
40. San George, R. C.; Hoberman H. D. Reaction of acetaldehyde with hemoglobin. J. Biol. Chem. 1986, 261, 6811-6821.
41. Sillanaukee, P.; Hurme, L.; Tuominen, J.; Ranta, E.; Nikkara, S.; Seppa K. Structural characterisation of acetaldehyde adducts formed by a synthetic peptide mimicking the N-terminus of the hemoglobin β-chain under reducing and nonreducing conditions. Eur. J. Biochem. 1996, 240, 30-36.
42. Lin, R. C.; Smith, J. B.; Radtke, D. B.; Lumeng, L. Structural analysis of peptide-acetaldehyde adducts by mass spectrometry and production of antibodies directed against nonreduced protein-acetaldehyde adducts. Alcohol. Clin. Exp. Res. 1995, 19, 314-319.
43. Kerwin, B. A.; Heller, M. C.; Levin, S. H.; Randolph, T. W. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 °C of a recombinant hemoglobin. J. Pharm. Sci. 1998, 87, 1062-1068.
44. Bam, N. B.; Randolph, T. W.; Cleland, J. L. Stability of protein formulations: investigation of surfactant effects by a novel EPR technique. Pharm. Res. 1995, 12, 2-11.
45. Sukow, W. W.; Sandberg, H. E.; Lewis, E. A.; Eatough, D. J.; Hansen, L. D. Binding of the Triton X-100 series of nonionic surfactants to bovine serum albumin. Biochemistry 1980, 19, 912-917.
46. Sukow, W. W.; Bailey, J. Characterization of the binding of Triton X-100 to equine and rabbit serum albumin. Physiol. Chem. Phys. 1981, 13, 455-459.
47. Claesson, P. M.; Blomberg, E.; Frogberg, J. C.; Nylander, T.; Arnebrandt, T. Protein interactions at solid interfaces. Adv. Colloid. Interface Sci. 1995, 57, 161-227.
48. Thurow, H.; Geisen, K. Stabilization of dissolved proteins against denaturation at hydrophobic interfaces. Diabetologia 1984, 27, 212-218.
49. Ho, C.-H.; Britt, D. W.; Hlady, V. Human LDL and HSA adsorption onto model surfaces studied by total internal reflection fluorescence and scanning force microscopy. J. Mol. Recognit. 1996, 9, 444-455.
50. Buijs, J.; Hlady, V. Adsorption kinetics, conformation and mobility of growth hormone and lysozyme on solid surfaces, studied with TIRF. J. Colloid Interface Sci. 1997, 190, 171-181.